ESMO Breast Cancer 2023 Congress Coverage
ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients Who Discontinued Chemo Before Pembro and in Patients With Immune-Mediated AEs
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Hope Rugo
By
ESMO Breast Cancer 2023 Congress Coverage
FEATURING
Hope Rugo
Login to view comments.
Click here to Login
Videos